vnonline.co.uk provides the veterinary nursing profession with the latest news and industry developments, as well as events, resources, learning materials and careers.
Our website is dedicated to veterinary nurses and we strive to provide a platform where you can voice and explore your interests.
Register for free with vnonline.co.uk to gain unlimited access to news, resources, jobs and much more!
Posted: 16th October 2018
Sale of Saint-Herblon site expected to complete in early 2019
Boehringer Ingelheim has announced the sale of its production site in Saint-Herblon, France, to Dutch company Dopharma.
First announced in October last year, the move follows the presentation of Boehringer’s animal health strategic orientations.
The group confirmed its strategy to focus on advanced and preventative healthcare; Saint-Herblon mainly produces generics and antibiotics for livestock.
Dopharma is an independent, family-owned company that develops, produces and distributes veterinary products for livestock.
Erick Lelouche, president of Boehringer Ingelheim Animal Health in France, said: “I am convinced that this project will offer a solid foundation for the future to the site and its employees. Indeed, we will collaborate with Dopharma Saint-Herblon that will produce some of our specialized products during the coming years.”
The sale is expected to complete by the end of the first quarter of 2019, after the legal and consultation process is finalised.
Become a member or log in to add this story to your CPD history
Birmingham Dogs Home has issued an urgent winter appeal as it faces more challenges over the Christmas period.
